Financhill
Back

Catalyst Pharmaceuticals Vs. Enphase Energy Industry Stock Comparison

Sell
42

CPRX
Catalyst Pharmaceuticals

Last Price:
14.88
Seasonality Move:
2.11%
Sell
39

ENPH
Enphase Energy

Last Price:
111.91
Seasonality Move:
13.12%
Sell
42
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $14.89. The Score for CPRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Enphase Energy (ENPH) is a Sell

Is Enphase Energy a Buy, Sell or Hold?

  • The current Enphase Energy [ENPH] share price is $111.93. The Score for ENPH is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ENPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $14.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight buying pressure.

ENPH Stock Price Chart

What is Enphase Energy's stock price today?

  • The Enphase Energy share price today is $111.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENPH is experiencing slight selling pressure.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 44.08 Sell
Chaikin Money Flow: 32626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.05 - 15.87) Sell
Bollinger Bands (100): (14.04 - 16.2) Sell

ENPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.18 Sell
Relative Strength Index (14 RSI): 48 Sell
Chaikin Money Flow: -1117554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (109.5 - 119.02) Sell
Bollinger Bands (100): (107.2 - 126.5) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.12 Sell
20-day SMA: 15.35 Sell
50-day SMA: 15.5 Sell
200-day SMA: 14.21 Buy
8-day EMA: 15.05 Sell
20-day EMA: 15.31 Sell
50-day EMA: 15.33 Sell
200-day EMA: 14.59 Buy

ENPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.83 Buy
20-day SMA: 114.03 Sell
50-day SMA: 118.13 Sell
200-day SMA: 119.3 Sell
8-day EMA: 110.64 Buy
20-day EMA: 112.89 Sell
50-day EMA: 115.11 Sell
200-day EMA: 128.4 Sell

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Enphase Energy Earnings Growth & ENPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.27 per share, a decrease this year of $1.47 per share, and an increase next year of $2.19 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Enphase Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):